ACE and Chagas disease: Based on the potential use of the genetic marker in the clinical practice and theinconclusive results regarding the role of ACE polymorphism as a risk factor for thedevelopment of HF secondary to Chagas disease, this genetic marker was shown not tobe useful in the clinical practice.